PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)

Press/Media: Press / Media

Period2018 Oct 2 → 2020 Sep 12

Media coverage

2

Media coverage

  • TitlePegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)
    Media name/outletDrug Genius
    CountryUnited States
    Date20/9/12
    URLct.moreover.com/?a=43060596422&p=1gw&v=1&x=TNR294rBesGHXtZHwkANWA
    PersonsJunyong Park
  • TitlePegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date18/10/2
    PersonsJunyong Park